Memory Pharmaceuticals

                   

[Neuroscience] Neuroligin-1 is required for normal expression of LTP and associative fear memory...

nas.edu     Jul 1, 2008          

†J.K. and S.-Y.J. contributed equally to this work. (received for review February 21, 2008) Abstract Neuroligin-1 is a potent trigger for the de novo formation of synaptic connections, and it has recently been suggested that it...                

comments

[Letters to the Editor] Interpreting T Scores and Percentile Equivalents Using the MATRICS...

psychiatryonline.org     Jul 1, 2008          

Ringoes, N.J. To the Editor: In the February 2008 issue of the Journal, Robert S. Kern, Ph.D. et al. (1) presented normative data for the National Institute of Mental Health’s Measurement and Treatment Research to Improve...                

comments

RXi Follows Public Listing with $8.7M Private Placement

tmcnet.com     Jun 24, 2008   5 related          

Financings Roundup In a deal expected to close today, RXi Pharmaceuticals Corp. is raising $8.7 million through the private placement of 1.1 million shares of common stock priced at $8.12 per share. That differentiates it from...                

comments

                   

Memory Pharmaceuticals Closes Second Tranche of Equity Financing With The Stanley Medical...

redorbit.com     Jun 24, 2008   10 related          

Posted on: Tuesday, 24 June 2008, 06:03 CDT MONTVALE, N.J., June 24 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. today announced that it has secured $2 million through the sale of approximately 4.7 million shares of...                

comments

InPlay: Advanced Medical Optics enters into cross-licensing agreement patent with Alcon...

yahoo.com     Jun 24, 2008   6 related          

6:12AM On The Wires : Memory Pharmaceuticals (MEMY) announces that it has secured $2 mln through the sale of approx 4.7 mln shares of common stock under its equity financing agreement with an investment group led by The Stanley...                

comments

Momenta Pharmaceuticals Announces Appointment of James R. Sulat to Board of Directors

primenewswire.com     Jun 11, 2008   5 related          

CAMBRIDGE, Mass., June 11, 2008 (PRIME NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced the appointment of...                

comments

Memory Pharmaceuticals Receives Anticipated NASDAQ Staff Determination Letter

redorbit.com     Jun 9, 2008          

Posted on: Monday, 9 June 2008, 06:00 CDT MONTVALE, N.J., June 9 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. today announced that on June 6, 2008 it received a letter from the NASDAQ Listing Qualifications Department...                

comments

                   

Memory Pharmaceuticals Highlights Progress with Key Programs at its R&D Day

drugs.com     May 19, 2008          

MONTVALE, N.J., May 16, 2008 /PRNewswire-FirstCall/ -- The Company reported new clinical data for MEM 1414, its lead PDE4 inhibitor, demonstrating the compound's CNS activity in humans. In addition, the Company has nominated MEM 68626 as the lead development candidate from its 5-HT6 antagonist...                

comments

                   

Memory Pharmaceuticals Highlights Progress With Key Programs At Its R&D Day

medicalnewstoday.com     May 17, 2008   4 related          

Memory Pharmaceuticals Corp. (Nasdaq: MEMY) announced progress with several key development programs at its R&D Day meeting with the investment community. The Company reported new clinical data for MEM 1414, its lead PDE4 inhibitor, demonstrating the compound's CNS activity in humans.                

comments

The Maybach Journal: Memory Pharmaceuticals Reports First Quarter 2008 Financial Results

tmcnet.com     May 14, 2008   3 related          

MaybachFinancial.com is one of the fastest growing independent and unbiased research firms in the world. Investors wanting to know the truth about investing and how to consistently profit from whatever the markets throw our way should sign up to www.maybachfinancial.com for a free trial...                

comments

1 2 3 4 5 next »